Abstract
In this issue of Blood, Stamatopoulos and colleagues present evidence that down-regulation of miR-29c and miR-223 in malignant B cells is an adverse prognostic indicator in CLL. The findings in this paper are remarkable in that they help refine disease stratification and prognosis.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 5035-5036 |
| Number of pages | 2 |
| Journal | Blood |
| Volume | 113 |
| Issue number | 21 |
| DOIs |
|
| State | Published - 2009 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology